These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
182 related articles for article (PubMed ID: 39318195)
1. Different leukocyte subsets are targeted by systemic and locoregional administration despite conserved nanomaterial characteristics optimal for lymph node delivery. Archer PA; Heiler AJ; Bourque AR; Alapan Y; Thomas SN Biomater Sci; 2024 Oct; 12(21):5582-5597. PubMed ID: 39318195 [TBL] [Abstract][Full Text] [Related]
2. Quantitation of lymphatic transport mechanism and barrier influences on lymph node-resident leukocyte access to lymph-borne macromolecules and drug delivery systems. Archer PA; Sestito LF; Manspeaker MP; O'Melia MJ; Rohner NA; Schudel A; Mei Y; Thomas SN Drug Deliv Transl Res; 2021 Dec; 11(6):2328-2343. PubMed ID: 34165731 [TBL] [Abstract][Full Text] [Related]
3. Lymph-directed nitric oxide increases immune cell access to lymph-borne nanoscale solutes. Sestito LF; Thomas SN Biomaterials; 2021 Jan; 265():120411. PubMed ID: 33080460 [TBL] [Abstract][Full Text] [Related]
4. Efficient antigen delivery to the draining lymph nodes is a key component in the immunogenic pathway of the intradermal vaccine. Tozuka M; Oka T; Jounai N; Egawa G; Ishii KJ; Kabashima K; Takeshita F J Dermatol Sci; 2016 Apr; 82(1):38-45. PubMed ID: 26674124 [TBL] [Abstract][Full Text] [Related]
5. New concept for the prevention and treatment of metastatic lymph nodes using chemotherapy administered via the lymphatic network. Kodama T; Matsuki D; Tada A; Takeda K; Mori S Sci Rep; 2016 Sep; 6():32506. PubMed ID: 27581921 [TBL] [Abstract][Full Text] [Related]
6. Winner of the society for biomaterials young investigator award for the annual meeting of the society for biomaterials, April 11-14, 2018, Atlanta, GA: S-nitrosated poly(propylene sulfide) nanoparticles for enhanced nitric oxide delivery to lymphatic tissues. Schudel A; Sestito LF; Thomas SN J Biomed Mater Res A; 2018 Jun; 106(6):1463-1475. PubMed ID: 29352735 [TBL] [Abstract][Full Text] [Related]
7. Optimization of the delivery of molecules into lymph nodes using a lymphatic drug delivery system with ultrasound. Kato S; Yoshiba S; Mori S; Kodama T Int J Pharm; 2021 Mar; 597():120324. PubMed ID: 33540016 [TBL] [Abstract][Full Text] [Related]
8. Optimal range of injection rates for a lymphatic drug delivery system. Fujii H; Horie S; Takeda K; Mori S; Kodama T J Biophotonics; 2018 Aug; 11(8):e201700401. PubMed ID: 29461015 [TBL] [Abstract][Full Text] [Related]
9. Perinodal Adipose Tissue Participates in Immune Protection through a Lymphatic Vessel-Independent Route. Lin Y; Leung G; Louie D; Bogoslowski A; Ross J; Kubes P; von der Weid PY; Liao S J Immunol; 2018 Jul; 201(1):296-305. PubMed ID: 29760196 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel administered through a novel lymphatic drug delivery system (LDDS) improved treatment outcomes for lymph node metastasis. Sukhbaatar A; Mori S; Sugiura T; Kodama T Biomed Pharmacother; 2024 Feb; 171():116085. PubMed ID: 38171241 [TBL] [Abstract][Full Text] [Related]
11. The Kinetics of Lymphatic Dysfunction and Leukocyte Expansion in the Draining Lymph Node during LTB Cribb MT; Sestito LF; Rockson SG; Nicolls MR; Thomas SN; Dixon JB Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923272 [TBL] [Abstract][Full Text] [Related]
12. Cancer cells regulate lymphocyte recruitment and leukocyte-endothelium interactions in the tumor-draining lymph node. Carrière V; Colisson R; Jiguet-Jiglaire C; Bellard E; Bouche G; Al Saati T; Amalric F; Girard JP; M'Rini C Cancer Res; 2005 Dec; 65(24):11639-48. PubMed ID: 16357175 [TBL] [Abstract][Full Text] [Related]
13. Blockade of immune checkpoints in lymph nodes through locoregional delivery augments cancer immunotherapy. Francis DM; Manspeaker MP; Schudel A; Sestito LF; O'Melia MJ; Kissick HT; Pollack BP; Waller EK; Thomas SN Sci Transl Med; 2020 Sep; 12(563):. PubMed ID: 32998971 [TBL] [Abstract][Full Text] [Related]
14. Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response. Thomas SN; Vokali E; Lund AW; Hubbell JA; Swartz MA Biomaterials; 2014 Jan; 35(2):814-24. PubMed ID: 24144906 [TBL] [Abstract][Full Text] [Related]
15. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution. Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776 [TBL] [Abstract][Full Text] [Related]
16. Nanomaterial-Based Drug Delivery System Targeting Lymph Nodes. Cheng Z; Que H; Chen L; Sun Q; Wei X Pharmaceutics; 2022 Jun; 14(7):. PubMed ID: 35890268 [TBL] [Abstract][Full Text] [Related]
17. Halted Lymphocyte Egress via Efferent Lymph Contributes to Lymph Node Hypertrophy During Hypercholesterolemia. Tay MHD; Lim SYJ; Leong YFI; Thiam CH; Tan KW; Torta FT; Narayanaswamy P; Wenk M; Angeli V Front Immunol; 2019; 10():575. PubMed ID: 30972070 [TBL] [Abstract][Full Text] [Related]
18. Flexible Macromolecule versus Rigid Particle Retention in the Injected Skin and Accumulation in Draining Lymph Nodes Are Differentially Influenced by Hydrodynamic Size. Rohner NA; Thomas SN ACS Biomater Sci Eng; 2017 Feb; 3(2):153-159. PubMed ID: 29888321 [TBL] [Abstract][Full Text] [Related]
19. Use of a Lymphatic Drug Delivery System and Sonoporation to Target Malignant Metastatic Breast Cancer Cells Proliferating in the Marginal Sinuses. Kato S; Shirai Y; Sakamoto M; Mori S; Kodama T Sci Rep; 2019 Sep; 9(1):13242. PubMed ID: 31519920 [TBL] [Abstract][Full Text] [Related]
20. Treatment of false-negative metastatic lymph nodes by a lymphatic drug delivery system with 5-fluorouracil. Fujii H; Horie S; Sukhbaatar A; Mishra R; Sakamoto M; Mori S; Kodama T Cancer Med; 2019 May; 8(5):2241-2251. PubMed ID: 30945479 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]